Department of Pharmacology, University of Oxford, OX1 3QT, Oxford, United Kingdom.
Department of Pharmacology, University of Oxford, OX1 3QT, Oxford, United Kingdom
J Neurosci. 2020 Aug 19;40(34):6557-6571. doi: 10.1523/JNEUROSCI.0740-20.2020. Epub 2020 Jul 24.
A reduction in the synthesis of the neuromodulator histamine has been associated with Tourette's syndrome and obsessive-compulsive disorder. Symptoms of these disorders are thought to arise from a dysfunction or aberrant development ofcorticostriatal circuits. Here, we investigated how histamine affects developing corticostriatal circuits, both acutely and longer-term, during the first postnatal weeks, using patch-clamp and field recordings in mouse brain slices (C57Bl/6, male and female). Immunohistochemistry for histamine-containing axons reveals striatal histaminergic innervation by the second postnatal week, and qRT-PCR shows transcripts for H, H, and H histamine receptors in striatum from the first postnatal week onwards, with pronounced developmental increases in H receptor expression. Whole-cell patch-clamp recordings of striatal spiny projection neurons and histamine superfusion demonstrates expression of functional histamine receptors from the first postnatal week onwards, with histamine having diverse effects on their electrical properties, including depolarization of the membrane potential while simultaneously decreasing action potential output. Striatal field recordings and electrical stimulation of corticostriatal afferents revealed that histamine, acting at H receptors, negatively modulates corticostriatal synaptic transmission from the first postnatal week onwards. Last, we investigated effects of histamine on longer-term changes at developing corticostriatal synapses and show that histamine facilitates NMDA receptor-dependent LTP via H receptors during the second postnatal week, but inhibits synaptic plasticity at later developmental stages. Together, these results show that histamine acutely modulates developing striatal neurons and synapses and controls longer-term changes in developing corticostriatal circuits, thus providing insight into the possible etiology underlying neurodevelopmental disorders resulting from histamine dysregulation. Monogenic causes of neurologic disorders, although rare, can provide opportunities to both study and understand the brain. For example, a nonsense mutation in the coding gene for the histamine-synthesizing enzyme has been associated with Tourette's syndrome and obsessive-compulsive disorder, and dysfunction of corticostriatal circuits. Nevertheless, the etiology of these neurodevelopmental disorders and histamine's role in the development of corticostriatal circuits have remained understudied. Here we show that histamine is an active neuromodulator during the earliest periods of postnatal life and acts at developing striatal neurons and synapses. Crucially, we show that histamine permits NMDA receptor-dependent corticostriatal synaptic plasticity during an early critical period of postnatal development, which suggests that genetic or environmental perturbations of histamine levels can impact striatal development.
神经调质组胺的合成减少与妥瑞氏症和强迫症有关。这些疾病的症状被认为是皮质纹状体回路功能障碍或异常发育引起的。在这里,我们使用在体脑片(C57Bl/6,雄性和雌性)中的膜片钳和场记录技术,研究了组胺在新生后第一周内是如何急性和长期地影响皮质纹状体回路的发育。组织化学显示组胺能轴突支配纹状体的支配从第二周开始,qRT-PCR 显示从第一周开始纹状体中 H1、H2 和 H3 组胺受体的转录物,H1 受体的表达明显增加。纹状体棘突投射神经元的全细胞膜片钳记录和组胺灌流显示从第一周开始功能性组胺受体的表达,组胺对其电生理特性有多种影响,包括膜电位去极化,同时减少动作电位输出。纹状体场记录和皮质纹状体传入神经的电刺激显示,组胺通过 H1 受体负调节从第一周开始的皮质纹状体突触传递。最后,我们研究了组胺对发育中的皮质纹状体突触的长期变化的影响,并表明组胺通过 H1 受体在第二周促进 NMDA 受体依赖性 LTP,但在后期发育阶段抑制突触可塑性。总之,这些结果表明,组胺急性调节发育中的纹状体神经元和突触,并控制发育中的皮质纹状体回路的长期变化,从而为组胺失调导致的神经发育障碍的潜在病因提供了深入了解。神经障碍的单基因病因虽然罕见,但可以为研究和理解大脑提供机会。例如,编码组胺合成酶的编码基因突变与妥瑞氏症和强迫症以及皮质纹状体回路功能障碍有关。然而,这些神经发育障碍的病因和组胺在皮质纹状体回路发育中的作用仍未得到充分研究。在这里,我们表明组胺是新生后生命早期的一种活跃的神经调质,作用于发育中的纹状体神经元和突触。至关重要的是,我们表明,组胺允许 NMDA 受体依赖性皮质纹状体突触可塑性在新生后发育的早期关键时期发生,这表明组胺水平的遗传或环境干扰会影响纹状体发育。